ANI Pharmaceuticals, Inc. (ANIP) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
Strength Seen in ANI (ANIP): Can Its 10.6% Jump Turn into More Strength?Zacks Investment Research • 01/13/26
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic PrioritiesGlobeNewsWire • 01/12/26
ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/06/26
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 12/31/25
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked AwayThe Motley Fool • 12/28/25
ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina FranchiseGlobeNewsWire • 12/02/25
ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewsWire • 11/25/25
Here's How ANIP's Rare Disease Portfolio Is Driving Top-line GrowthZacks Investment Research • 11/21/25
ANI (ANIP) Loses 15% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 11/19/25
ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – LondonGlobeNewsWire • 11/11/25
Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/07/25